James Michael Rusnak, Age 57Tampa, FL

James Rusnak Phones & Addresses

Tampa, FL

Hollis, NH

3 Aberdeen Ct, East Lyme, CT 06333 (860) 451-8092 (860) 451-8093

640 Pineville Rd, Newtown, PA 18940

Upper Makefield, PA

174 Cinnabar Ln, Morrisville, PA 19067

Yardley, PA

Nashua, NH

Springdale, PA

Rochester, MN

Buck, PA

197 Dow Rd, Hollis, NH 03049

Show more

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

School / High School: University of Pittsburgh / School of Dentistry

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 2000

Mentions for James Michael Rusnak

Career records & work history

Medicine Doctors

James Rusnak Photo 1

Dr. James M Rusnak, East Lyme CT - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
3 Aberdeen Ct, East Lyme, CT 06333
(860) 389-0426 (Phone) (860) 451-8093 (Fax)
Certifications:
Internal Medicine, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Pittsburgh / School of Dentistry
Medical School
Mayo Clinic-Rochester
James Rusnak Photo 2

James Michael Rusnak

Specialties:
Internal Medicine
Education:
University of Pittsburgh(1997)

License Records

James J Rusnak

Licenses:
License #: RS126998A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

James W Rusnak

Licenses:
License #: RS089491A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

James Rusnak resumes & CV records

Resumes

James Rusnak Photo 23

James Rusnak

James Rusnak Photo 24

James Rusnak

James Rusnak Photo 25

James Rusnak

James Rusnak Photo 26

James Rusnak

Location:
United States
James Rusnak Photo 27

James Rusnak

Location:
United States
James Rusnak Photo 28

James Rusnak

Location:
United States

Publications & IP owners

Us Patents

Methods For Treating Cardiovascular Disease Using A Soluble Ctla4 Molecule

US Patent:
7307064, Dec 11, 2007
Filed:
Aug 3, 2004
Appl. No.:
10/910531
Inventors:
James Rusnak - Newtown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/17
A61K 39/395
C07K 14/725
C07K 16/46
US Classification:
514 21, 514 12, 4241341, 530350, 5303873
Abstract:
The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.

Methods For Treating Immune Disorders Associated With Graft Transplantation With Soluble Ctla4 Mutant Molecules

US Patent:
7482327, Jan 27, 2009
Filed:
Apr 6, 2006
Appl. No.:
11/399666
Inventors:
David Hagerty - Pennington NJ, US
James Rusnak - Newtown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/16
US Classification:
514 12, 4241341
Abstract:
The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.

Methods For Treating Cardiovascular Disease Using A Soluble Ctla4 Molecule

US Patent:
7671022, Mar 2, 2010
Filed:
Aug 14, 2007
Appl. No.:
11/892000
Inventors:
James Rusnak - Newtown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/16
US Classification:
514 12
Abstract:
The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.

Methods For Treating Cardiovascular Disease Using A Soluble Ctla4 Molecule

US Patent:
2009004, Feb 12, 2009
Filed:
Oct 19, 2007
Appl. No.:
11/975659
Inventors:
James Rusnak - Newtown PA, US
International Classification:
A61K 39/395
A61K 38/17
US Classification:
4241781, 514 12
Abstract:
The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.

Methods For Treating Immune Disorders Associated With Graft Transplantation With Soluble Ctla4 Mutant Molecules

US Patent:
2010004, Feb 18, 2010
Filed:
Nov 19, 2008
Appl. No.:
12/313342
Inventors:
David Hagerty - Cardiff by the Sea CA, US
James Rusnak - Newtown PA, US
International Classification:
A61K 38/16
A61P 37/06
US Classification:
514 12
Abstract:
The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.

Methods Of Treating Or Reducing The Risk Of Cardiovascular Events And Relted Diseases Using Sglt-2 Inhibitors

US Patent:
2020003, Feb 6, 2020
Filed:
Oct 10, 2019
Appl. No.:
16/597894
Inventors:
- Rahway NJ, US
- New York NY, US
Steven G. Terra - Middleton MA, US
James M. Rusnak - Hollis NH, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
Pfizer Inc. - New York NY
International Classification:
A61K 31/357
A61K 31/155
A61K 31/7048
A61K 31/4985
A61P 9/10
A61P 9/04
Abstract:
The present invention relates to the use of certain SGLT-2 inhibitors, such as ertugliflozin or a pharmaceutically acceptable salt or a co-crystal thereof, for treating, reducing the risk of and/or preventing heart failure, myocardial infarction, cardiovascular disease or cardiovascular death in animals without type 2 or type 1 diabetes mellitus, or in animals with pre-diabetes, or in animals with type 2 or type 1 diabetes mellitus or pre-diabetes.

Amazon

James Rusnak Photo 30

Comparison Of Oregon State Highway Division Table-1 And Table-2 Asphalt

Author:
James S Rusnak
Publisher:
Oregon State Highway Division, Materials and Research Section
Binding:
Unknown Binding
A semi-autobiographical account of Seow's experiences as a government official and his 72-day detention in 1988 for (quote) courting if not colluding (unquote) with U.S. diplomats to build an opposition in Singapore
James Rusnak Photo 31

Preformed, Patterned Striping Material: Stamark Pliant Marking Tape, Series 5730, Series A350 (Oregon Experimental Feature Project)

Author:
James S Rusnak
Publisher:
Oregon State Highway Division, Materials and Research Section
Binding:
Unknown Binding
James Rusnak Photo 32

Woodburn Hot In-Plant Asphalt Pavement Recycling Project: Final Report (Experimental Features Project)

Author:
James S Rusnak
Publisher:
Oregon Dept. of Transportation, Materials and Research Section, Research Unit
Binding:
Unknown Binding
Pages:
25

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.